Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Fibrosarcoma and BRAF[original query] |
|---|
| Population-level effect of molecular testing and targeted therapy in patients with advanced pulmonary adenocarcinoma: a prospective cohort study. Virchows Archiv : an international journal of pathology 2018 Apr 472 (4): 581-588. Schwegler Christine, Kaufmann Dinu, Pfeiffer David, Aebi Stefan, Diebold Joachim, Gautschi Oliv |
| Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients. Oncotarget 2017 (44): 75914-75923. Morgese Francesca, Soldato Davide, Pagliaretta Silvia, Giampieri Riccardo, Brancorsini Donatella, Torniai Mariangela, Rinaldi Silvia, Savini Agnese, Onofri Azzurra, Scarpelli Marina, Berardi Rossa |
| Survival Outcomes in Patients With RAS Wild Type Metastatic Colorectal Cancer Classified According to Köhne Prognostic Category and BRAF Mutation Status. Clinical colorectal cancer 2017 11 17 (1): 50-57.e8. Siena Salvatore, Rivera Fernando, Taieb Julien, Peeters Marc, Prenen Hans, Koukakis Reija, Demonty Gaston, Köhne Claus-Henni |
| BRAF V600E and previously unidentified KRAS G12C mutations in odontogenic tumors may affect MAPK activation differently depending on tumor type. Genes, chromosomes & cancer 2022 3 61 (8): 481-490. Oh Kyu-Young, Kim Ji-Hoon, Cho Sung-Dae, Yoon Hye-Jung, Lee Jae-Il, Hong Seong-D |
- Page last reviewed:Feb 1, 2024
- Content source: